Nu Skin Enterprises Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises or view top-rated stocks.

3 brokers have issued twelve-month price objectives for Nu Skin Enterprises' stock. Their NUS stock forecasts range from $49.00 to $75.00. On average, they expect Nu Skin Enterprises' stock price to reach $61.50 in the next twelve months. This suggests a possible upside of 37.7% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $50.75 at the beginning of 2022. Since then, NUS stock has decreased by 12.0% and is now trading at $44.65.
View the best growth stocks for 2022 here.

Nu Skin Enterprises saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 3,660,000 shares, a decline of 22.5% from the May 15th total of 4,720,000 shares. Based on an average trading volume of 604,100 shares, the days-to-cover ratio is currently 6.1 days. Approximately 7.5% of the shares of the company are short sold.
View Nu Skin Enterprises' Short Interest.

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Nu Skin Enterprises.

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings data on Wednesday, May, 4th. The company reported $0.76 earnings per share for the quarter, topping analysts' consensus estimates of $0.73 by $0.03. The business earned $604.90 million during the quarter, compared to the consensus estimate of $579.70 million. Nu Skin Enterprises had a net margin of 5.28% and a trailing twelve-month return on equity of 22.05%. The firm's quarterly revenue was down 10.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.91 earnings per share.
View Nu Skin Enterprises' earnings history.

Nu Skin Enterprises declared a quarterly dividend on Wednesday, May 4th. Investors of record on Friday, May 27th will be paid a dividend of $0.385 per share on Wednesday, June 8th. This represents a $1.54 annualized dividend and a dividend yield of 3.45%. The ex-dividend date is Thursday, May 26th.
View Nu Skin Enterprises' dividend history.

Nu Skin Enterprises(NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.44%. Nu Skin Enterprises has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Nu Skin Enterprises is 57.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 37.65% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

Nu Skin Enterprises issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of $3.60-$3.90 for the period, compared to the consensus estimate of $4.21. The company issued revenue guidance of $2.51 billion-$2.62 billion, compared to the consensus revenue estimate of $2.70 billion.

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Nu Skin Enterprises include Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Herbalife Nutrition (HLF), Inter Parfums (IPAR), Medifast (MED), USANA Health Sciences (USNA), Veru (VERU), Revlon (REV) and Nature's Sunshine Products (NATR).
View all of NUS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NUS stock can currently be purchased for approximately $44.65.

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.24 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.70 on an earnings per share basis.

Nu Skin Enterprises employs 4,600 workers across the globe.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for Nu Skin Enterprises is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.